NDC 0527-1396 – Loxapine
Loxapine Succinate 25 mg/1 · Capsule · Oral
Product NDC0527-1396
Product details
- Brand name
- Loxapine
- Generic name
- Loxapine
- Labeler
- Lannett Company, Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA090695
- Marketed since
- September 26, 2011
- Listing expires
- December 31, 2026
Active ingredients
- Loxapine Succinate 25 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0527-1396-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (0527-1396-01) | Sep 26, 2011 |
| 0527-1396-10 | 1000 CAPSULE in 1 BOTTLE, PLASTIC (0527-1396-10) | Sep 26, 2011 |
Other Loxapine products
- 0591-0369 Loxapine Succinate 5 mg/1 · Capsule · Actavis Pharma, Inc.
- 0591-0370 Loxapine Succinate 10 mg/1 · Capsule · Actavis Pharma, Inc.
- 0591-0371 Loxapine Succinate 25 mg/1 · Capsule · Actavis Pharma, Inc.
- 0591-0372 Loxapine Succinate 50 mg/1 · Capsule · Actavis Pharma, Inc.
- 62135-492 Loxapine Succinate 5 mg/1 · Capsule · Chartwell RX, LLC
- 62135-493 Loxapine Succinate 10 mg/1 · Capsule · Chartwell RX, LLC
- 67046-1485 Loxapine Succinate 10 mg/1 · Capsule · Coupler LLC
- 67046-1479 Loxapine Succinate 5 mg/1 · Capsule · Coupler LLC
- 67046-1478 Loxapine Succinate 25 mg/1 · Capsule · Coupler LLC
- 64850-890 Loxapine Succinate 5 mg/1 · Capsule · Elite Laboratories, Inc.
- 64850-891 Loxapine Succinate 10 mg/1 · Capsule · Elite Laboratories, Inc.
- 64850-892 Loxapine Succinate 25 mg/1 · Capsule · Elite Laboratories, Inc.